Impact of KRAS/BRAF Mutations in Patients with Colorectal Peritoneal Metastases

被引：0
|
作者：
Wright, G. [1 ]
Zureikat, A. [1 ]
Pingpank, J. F. [1 ]
Holtzman, M. [1 ]
Ahrendt, S. [1 ]
Ramalingam, L. [1 ]
Zeh, H., III [1 ]
Bartlett, D. [1 ]
Choudry, M. A. [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Surg Oncol, Pittsburgh, PA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2016年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P148
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [41] Frequency of KRAS/BRAF mutations as predictive markers for Cetuximab in Japanese colorectal cancer patients
    Yokota, T.
    Shibata, N.
    Ura, T.
    Takahari, D.
    Shitara, K.
    Muro, K.
    Yatabe, Y.
    EJC SUPPLEMENTS, 2009, 7 (02): : 351 - 351
  • [42] KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study
    Negru, Serban
    Papadopoulou, Eirini
    Apessos, Angela
    Stanculeanu, Dana Lucia
    Ciuleanu, Eliade
    Volovat, Constantin
    Croitoru, Adina
    Kakolyris, Stylianos
    Aravantinos, Gerasimos
    Ziras, Nikolaos
    Athanasiadis, Elias
    Touroutoglou, Nikolaos
    Pavlidis, Nikolaos
    Kalofonos, Haralabos P.
    Nasioulas, George
    BMJ OPEN, 2014, 4 (05):
  • [43] KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer
    Renaud, S.
    Romain, B.
    Falcoz, P-E
    Olland, A.
    Santelmo, N.
    Brigand, C.
    Rohr, S.
    Guenot, D.
    Massard, G.
    BRITISH JOURNAL OF CANCER, 2015, 112 (04) : 720 - 728
  • [44] KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer
    S Renaud
    B Romain
    P-E Falcoz
    A Olland
    N Santelmo
    C Brigand
    S Rohr
    D Guenot
    G Massard
    British Journal of Cancer, 2015, 112 : 720 - 728
  • [45] Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients
    Hsu, Hung-Chih
    Thiam, Tan Kien
    Lu, Yen-Jung
    Yeh, Chien Yuh
    Tsai, Wen-Sy
    You, Jeng Fu
    Hung, Hsin Yuan
    Tsai, Chi-Neu
    Hsu, An
    Chen, Hua-Chien
    Chen, Shu-Jen
    Yang, Tsai Sheng
    ONCOTARGET, 2016, 7 (16) : 22257 - 22270
  • [46] Distinct impacts of KRAS, NRAS and BRAF mutations on survival of patients with metastatic colorectal cancer
    Wang, Yucai
    Loree, Jonathan M.
    Yu, Cecilia
    Tschautscher, Marcella
    Briggler, Andrew M.
    Overman, Michael J.
    Broaddus, Russell
    Meric-Bernstam, Funda
    Jones, Jeremy Clifton
    Balcom, Jessica
    Kipp, Benjamin
    Kopetz, Scott
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [47] Alterations of mTOR signaling impact metabolic stress resistance in colorectal carcinomas with BRAF and KRAS mutations
    Raphaela Fritsche-Guenther
    Christin Zasada
    Guido Mastrobuoni
    Nadine Royla
    Roman Rainer
    Florian Roßner
    Matthias Pietzke
    Edda Klipp
    Christine Sers
    Stefan Kempa
    Scientific Reports, 8
  • [48] Alterations of mTOR signaling impact metabolic stress resistance in colorectal carcinomas with BRAF and KRAS mutations
    Fritsche-Guenther, Raphaela
    Zasada, Christin
    Mastrobuoni, Guido
    Royla, Nadine
    Rainer, Roman
    Rossner, Florian
    Pietzke, Matthias
    Klipp, Edda
    Sers, Christine
    Kempa, Stefan
    SCIENTIFIC REPORTS, 2018, 8
  • [49] Prevalence and Heterogeneity of KRAS, BRAF, and PIK3CA Mutations in Primary Colorectal Adenocarcinomas and Their Corresponding Metastases
    Baldus, Stephan E.
    Schaefer, Karl-L.
    Engers, Rainer
    Hartleb, Dinah
    Stoecklein, Nikolas H.
    Gabbert, Helmut E.
    CLINICAL CANCER RESEARCH, 2010, 16 (03) : 790 - 799
  • [50] Impact of microsatellite status on chemotherapy for colorectal cancer patients with KRAS or BRAF mutation
    Huang, Chi-Jung
    Huang, Shih-Hung
    Chien, Chih-Cheng
    Lee, Henry Hsin-Chung
    Yang, Shung-Haur
    Chang, Chun-Chao
    Lee, Chia-Long
    ONCOLOGY LETTERS, 2016, 12 (06) : 4427 - 4434
12345